Marizyme, Inc.

MRZM · OTC
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Operating Activities
Net Income-$4,493-$4,073-$6,226-$9,766
Dep. & Amort.$211$223$209$210
Deferred Tax$0$0$0$0
Stock-Based Comp.$21$42$54$6,217
Change in WC-$651$392$300$406
Other Non-Cash$3,930$2,666$4,854$1,718
Operating Cash Flow-$983-$750-$850-$1,257
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$0$0$0
Investing Cash Flow-$0$0$0$0
Financing Activities
Debt Repay.$1,042$249$667$381
Stock Issued$0$0$0$506
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$500$0$0
Financing Cash Flow$1,042$749$667$887
Forex Effect$0$0$0$0
Net Chg. in Cash$59-$1-$142-$326
Supplemental Information
Beg. Cash$5$6$148$475
End Cash$64$5$6$148
Free Cash Flow-$983-$750-$850-$1,257